Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Tziomalos, Konstantinos ^a   Dimitroula, Hariklia V ^a   Katsiki, Niki ^a   Savopoulos, Christos ^a   Hatzitolios, Apostolos I ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 20; INTERLEUKIN 6; INTERLEUKIN 8; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER;

ANTIINFLAMMATORY ACTIVITY; BARIATRIC SURGERY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIET RESTRICTION; DRUG EFFECT; DRUG MECHANISM; EXERCISE; HUMAN; IMMUNOMODULATION; INFLAMMATION; LIFESTYLE MODIFICATION; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; ROUX Y ANASTOMOSIS; STOMACH BYPASS; THERAPY EFFECT; WEIGHT REDUCTION; ANIMAL; BLOOD; DIET; IMMUNOLOGY; LIFESTYLE; METABOLISM;

ANIMALS; ANTI-OBESITY AGENTS; BARIATRIC SURGERY; BIOLOGICAL MARKERS; DIET; EXERCISE; HUMANS; INFLAMMATION; LIFE STYLE; OBESITY;

EID: 77951675090     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/364957     Document Type: Review

References (189)

1. Ogden C. L., Carroll M. D., Curtin L. R., McDowell M. A., Tabak C. J., Flegal K. M., Prevalence of overweight and obesity in the United States, 19992004 Journal of the American Medical Association 2006 295 13 1549 1555
2. James W. P. T., The epidemiology of obesity: the size of the problem Journal of Internal Medicine 2008 263 4 336 352
3. Pischon T., Boeing H., Hoffmann K., General and abdominal adiposity and risk of death in Europe The New England Journal of Medicine 2008 359 20 2105 2120
4. Adams K. F., Schatzkin A., Harris T. B., Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old The New England Journal of Medicine 2006 355 8 763 778
5. Hu F. B., Willett W. C., Li T., Stampfer M. J., Colditz G. A., Manson J. E., Adiposity as compared with physical activity in predicting mortality among women The New England Journal of Medicine 2004 351 26 2694 2703 (Pubitemid 39665323)
6. Fontana L., Eagon J. C., Trujillo M. E., Scherer P. E., Klein S., Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 2007 56 4 1010 1013 (Pubitemid 46525079)
7. Fain J. N., Madan A. K., Hiler M. L., Cheema P., Bahouth S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans Endocrinology 2004 145 5 2273 2282 (Pubitemid 38535056)
8. Fried S. K., Bunkin D. A., Greenberg A. S., Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid Journal of Clinical Endocrinology and Metabolism 1998 83 3 847 850
9. Mohamed-Ali V., Goodrick S., Rawesh A., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-, in vivo Journal of Clinical Endocrinology and Metabolism 1997 82 12 4196 4200 (Pubitemid 27525539)
10. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor- in human obesity and insulin resistance Journal of Clinical Investigation 1995 95 5 2409 2415
11. Kern P. A., Saghizadeh M., Ong J. M., Bosch R. J., Deem R., Simsolo R. B., The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase Journal of Clinical Investigation 1995 95 5 2111 2119
12. Bruun J. M., Lihn A. S., Pedersen S. B., Richelsen B., Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT Journal of Clinical Endocrinology and Metabolism 2005 90 4 2282 2289 (Pubitemid 40586275)
13. Christiansen T., Richelsen B., Bruun J. M., Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects International Journal of Obesity 2005 29 1 146 150 (Pubitemid 40065478)
14. Miller M., Zhan M., Havas S., High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey Archives of Internal Medicine 2005 165 18 2063 2068 (Pubitemid 41434580)
15. Visser M., Bouter L. M., McQuillan G. M., Wener M. H., Harris T. B., Elevated C-reactive protein levels in overweight and obese adults Journal of the American Medical Association 1999 282 22 2131 2135
16. Ford E. S., Body mass index, diabetes, and C-reactive protein among U.S. adults Diabetes Care 1999 22 12 1971 1977 (Pubitemid 30433974)
17. Hak A. E., Stehouwer C. D. A., Bots M. L., Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 8 1986 1991
18. Mora S., Lee I.-M., Buring J. E., Ridker P. M., Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women Journal of the American Medical Association 2006 295 12 1412 1419
19. Bermudez E. A., Rifai N., Buring J., Manson J. E., Ridker P. M., Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 10 1668 1673
20. Tchernof A., Nolan A., Sites C. K., Ades P. A., Poehlman E. T., Weight loss reduces C-reactive protein levels in obese postmenopausal women Circulation 2002 105 5 564 569 (Pubitemid 34123429)
21. Festa A., DAgostino R. Jr., Williams K., The relation of body fat mass and distribution to markers of chronic inflammation International Journal of Obesity 2001 25 10 1407 1415 (Pubitemid 32977855)
22. Heilbronn L. K., Noakes M., Clifton P. M., Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 6 968 970 (Pubitemid 34168654)
23. Festa A., DAgostino R. Jr., Howard G., Mykknen L., Tracy R. P., Haffner S. M., Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS) Circulation 2000 102 1 42 47 (Pubitemid 30430551)
24. Yudkin J. S., Stehouwer C. D. A., Emeis J. J., Coppack S. W., C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 4 972 978
25. Tracy R. P., Psaty B. M., Macy E., Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 10 2167 2176
26. Ziccardi P., Nappo F., Giugliano G., Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year Circulation 2002 105 7 804 809 (Pubitemid 34174919)
27. Pou K. M., Massaro J. M., Hoffmann U., Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study Circulation 2007 116 11 1234 1241 (Pubitemid 47517534)
28. Bastard J.-P., Jardel C., Bruckert E., Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss Journal of Clinical Endocrinology and Metabolism 2000 85 9 3338 3342
29. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., Wadden T., Tumor necrosis factor- in sera of obese patients: fall with weight loss Journal of Clinical Endocrinology and Metabolism 1998 83 8 2907 2910 (Pubitemid 28493796)
30. Mendall M. A., Patel P., Asante M., Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease Heart 1997 78 3 273 277 (Pubitemid 27431736)
31. Bruun J. M., Verdich C., Toubro S., Astrup A., Richelsen B., Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-. Effect of weight loss in obese men European Journal of Endocrinology 2003 148 5 535 542 (Pubitemid 36622161)
32. Straczkowski M., Dzienis-Straczkowska S., Stepien A., Kowalska I., Szelachowska M., Kinalska I., Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor- system Journal of Clinical Endocrinology and Metabolism 2002 87 10 4602 4606 (Pubitemid 35247047)
33. Esposito K., Pontillo A., Ciotola M., Weight loss reduces interleukin-18 levels in obese women Journal of Clinical Endocrinology and Metabolism 2002 87 8 3864 3866 (Pubitemid 34879540)
34. Straczkowski M., Lewczuk P., Dzienis-Straczkowska S., Kowalska I., Stepien A., Kinalska I., Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor- system activity Metabolism 2002 51 1 75 78 (Pubitemid 34092440)
35. Straczkowski M., Kowalska I., Dzienis-Straczkowska S., Changes in tumor necrosis factor- system and insulin sensitivity during an exercise training program in obese women with normal and impaired flucose tolerance European Journal of Endocrinology 2001 145 3 273 280 (Pubitemid 32825659)
36. Ferri C., Desideri G., Valenti M., Early upregulation of endothelial adhesion molecules in obese hypertensive men Hypertension 1999 34 4 568 573 (Pubitemid 29496435)
37. Pontiroli A. E., Pizzocri P., Koprivec D., Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans European Journal of Endocrinology 2004 150 2 195 200
38. Keaney J. F. Jr., Massaro J. M., Larson M. G., Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study Journal of the American College of Cardiology 2004 44 1 168 173
39. Lemieux I., Pascot A., Prudhomme D., Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 6 961 967
40. Katsuki A., Sumida Y., Murashima S., Serum levels of tumor necrosis factor- are increased in obese patients with noninsulin-dependent diabetes mellitus Journal of Clinical Endocrinology and Metabolism 1998 83 3 859 862
41. Couillard C., Ruel G., Archer W. R., Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity Journal of Clinical Endocrinology and Metabolism 2005 90 12 6454 6459
42. de Lemos J. A., Morrow D. A., Sabatine M. S., Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes Circulation 2003 107 5 690 695
43. Pradhan A. D., Manson J. E., Rossouw J. E., Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the womens health initiative observational study Journal of the American Medical Association 2002 288 8 980 987
44. Ridker P. M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E., Elevation of tumor necrosis factor- and increased risk of recurrent coronary events after myocardial infarction Circulation 2000 101 18 2149 2153
45. Ridker P. M., Rifai N., Stampfer M. J., Hennekens C. H., Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 2000 101 15 1767 1772
46. Buckley D. I., Fu R., Freeman M., Rogers K., Helfand M., C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force Annals of Internal Medicine 2009 151 7 483 495
47. Snow V., Barry P., Fitterman N., Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians Annals of Internal Medicine 2005 142 7 525 531
48. Tuomilehto J., Lindstrom J., Eriksson J. G., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance The New England Journal of Medicine 2001 344 18 1343 1350 (Pubitemid 32378388)
49. Knowler W. C., Barrett-Connor E., Fowler S. E., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin The New England Journal of Medicine 2002 346 6 393 403
50. Eilat-Adar S., Eldar M., Goldbourt U., Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor American Journal of Epidemiology 2005 161 4 352 358
51. Gregg E. W., Gerzoff R. B., Thompson T. J., Williamson D. F., Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older Annals of Internal Medicine 2003 138 5 383 389
52. Brinkworth G. D., Noakes M., Keogh J. B., Luscombe N. D., Wittert G. A., Clifton P. M., Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects International Journal of Obesity 2004 28 5 661 670
53. Brinkworth G. D., Noakes M., Parker B., Foster P., Clifton P. M., Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial Diabetologia 2004 47 10 1677 1686
54. Brinkworth G. D., Noakes M., Buckley J. D., Keogh J. B., Clifton P. M., Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo American Journal of Clinical Nutrition 2009 90 1 23 32
55. Clifton P. M., Keogh J. B., Foster P. R., Noakes M., Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets International Journal of Obesity 2005 29 12 1445 1451
56. Dansinger M. L., Gleason J. A., Griffith J. L., Selker H. P., Schaefer E. J., Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for weight loss and heart disease risk reduction: a randomized trial Journal of the American Medical Association 2005 293 1 43 53
57. Due A., Toubro S., Stender S., Skov A. R., Astrup A., The effect of diets high in protein or carbohydrate on inflammatory markers in overweight subjects Diabetes, Obesity and Metabolism 2005 7 3 223 229
58. Hannum S. M., Carson L., Evans E. M., Use of portion-controlled entrees enhances weight loss in women Obesity Research 2004 12 3 538 546
59. Heald A. H., Golding C., Sharma R., A substitution model of dietary manipulation is an effective means of optimising lipid profile, reducing C-reactive protein and increasing insulin-like growth factor-1 British Journal of Nutrition 2004 92 5 809 818
60. Kasim-Karakas S. E., Tsodikov A., Singh U., Jialal I., Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake American Journal of Clinical Nutrition 2006 83 4 774 779
61. Keogh J. B., Brinkworth G. D., Clifton P. M., Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin British Journal of Nutrition 2007 98 4 852 859
62. Keogh J. B., Brinkworth G. D., Noakes M., Belobrajdic D. P., Buckley J. D., Clifton P. M., Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity American Journal of Clinical Nutrition 2008 87 3 567 576
63. Mazzali G., Di Francesco V., Zoico E., Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women American Journal of Clinical Nutrition 2006 84 5 1193 1199
64. McLaughlin T., Abbasi F., Lamendola C., Differentiation between obesity and insulin resistance in the association with C-reactive protein Circulation 2002 106 23 2908 2912
65. Noakes M., Keogh J. B., Foster P. R., Clifton P. M., Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women American Journal of Clinical Nutrition 2005 81 6 1298 1306
66. Noakes M., Foster P. R., Keogh J. B., James A. P., Mamo J. C., Clifton P. M., Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk Nutrition and Metabolism 2006 3, article 7
67. OBrien K. D., Brehm B. J., Seeley R. J., Diet-induced weight loss is associated with decreases in plasma serum amyloid A and C-reactive protein independent of dietary macronutrient composition in obese subjects Journal of Clinical Endocrinology and Metabolism 2005 90 4 2244 2249
68. Pereira M. A., Swain J., Goldfine A. B., Rifai N., Ludwig D. S., Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss Journal of the American Medical Association 2004 292 20 2482 2490
69. Raitakari M., Ilvonen T., Ahotupa M., Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1 124 128
70. Ratliff J. C., Mutungi G., Puglisi M. J., Volek J. S., Fernandez M. L., Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men Nutrition and Metabolism 2008 5 1, article 6
71. Seshadri P., Iqbal N., Stern L., A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity American Journal of Medicine 2004 117 6 398 405
72. Sharman M. J., Volek J. S., Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men Clinical Science 2004 107 4 365 369
73. Tay J., Brinkworth G. D., Noakes M., Keogh J., Clifton P. M., Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects Journal of the American College of Cardiology 2008 51 1 59 67
74. Wood R. J., Volek J. S., Davis S. R., DellOva C., Fernandez M. L., Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease Nutrition and Metabolism 2006 3, article 19
75. Xydakis A. M., Case C. C., Jones P. H., Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight lose through caloric restriction Journal of Clinical Endocrinology and Metabolism 2004 89 6 2697 2703
76. Arvidsson E., Viguerie N., Andersson I., Verdich C., Langin D., Arner P., Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women Diabetes 2004 53 8 1966 1971
77. Xenachis C., Samojlik E., Raghuwanshi M. P., Kirschner M. A., Leptin, insulin and TNF- in weight loss Journal of Endocrinological Investigation 2001 24 11 865 870 (Pubitemid 34036716)
78. Manigrasso M. R., Ferroni P., Santilli F., Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss Journal of Clinical Endocrinology and Metabolism 2005 90 10 5876 5879 (Pubitemid 41415505)
79. Maiorino M. I., Schisano B., Di Palo C., Interleukin-20 circulating levels in obese women: effect of weight loss. Nutrition, Metabolism and Cardiovascular Diseases. In press
80. Porreca E., Di Febbo C., Fusco L., Moretta V., Di Nisio M., Cuccurullo F., Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese women Atherosclerosis 2004 172 1 175 180 (Pubitemid 38058617)
81. Mitchell J. R., Verweij M., Brand K., Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice Aging Cell 2010 9 40 53
82. Gugliucci A., Kotani K., Taing J., Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults Annals of Nutrition and Metabolism 2009 54 3 197 201
83. Campbell P. T., Campbell K. L., Wener M. H., A yearlong exercise intervention decreases CRP among obese postmenopausal women Medicine and Science in Sports and Exercise 2009 41 8 1533 1539
84. Kadoglou N. P. E., Iliadis F., Angelopoulou N., The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus European Journal of Cardiovascular Prevention and Rehabilitation 2007 14 6 837 843 (Pubitemid 350197015)
85. Olson T. P., Dengel D. R., Leon A. S., Schmitz K. H., Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women International Journal of Obesity 2007 31 6 996 1003
86. Okita K., Nishijima H., Murakami T., Can exercise training with weight loss lower serum C-reactive protein levels? Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 10 1868 1873 (Pubitemid 39350305)
87. Kondo T., Kobayashi I., Murakami M., Effect of exercise on circulating adipokine levels in obese young women Endocrine Journal 2006 53 2 189 195
88. Campbell K. L., Campbell P. T., Ulrich C. M., No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women Cancer Epidemiology Biomarkers and Prevention 2008 17 7 1714 1718
89. Devries M. C., Hamadeh M. J., Glover A. W., Raha S., Samjoo I. A., Tarnopolsky M. A., Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women Free Radical Biology and Medicine 2008 45 4 503 511
90. Dekker M. J., Lee S., Hudson R., An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus Metabolism 2007 56 3 332 338 (Pubitemid 46209224)
91. Tsukui S., Kanda T., Nara M., Nishino M., Kondo T., Kobayashi I., Moderate-intensity regular exercise decreases serum tumor necrosis factor- and HbA1c levels in healthy women International Journal of Obesity 2000 24 9 1207 1211
92. Huffman K. M., Slentz C. A., Bales C. W., Houmard J. A., Kraus W. E., Relationships between adipose tissue and cytokine responses to a randomized controlled exercise training intervention Metabolism 2008 57 4 577 583
93. Leick L., Lindegaard B., Stensvold D., Plomgaard P., Saltin B., Pilegaard H., Adipose tissue interleukin-18 mRNA and plasma interleukin-18: effect of obesity and exercise Obesity 2007 15 2 356 363 (Pubitemid 46407316)
94. St-Onge M.-P., Desmond R., Hunter G., Gower B., Baseline inflammatory markers do not modulate the lipid response to weight loss Metabolism 2008 57 5 598 604 (Pubitemid 351608219)
95. Sheu W. H.-H., Chang T.-M., Lee W.-J., Effect of weight loss on proinflammatory state of mononuclear cells in obese women Obesity 2008 16 5 1033 1038 (Pubitemid 351620479)
96. Dvorakova-Lorenzova A., Suchanek P., Havel P. J., The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin Metabolism 2006 55 3 359 365 (Pubitemid 43234390)
97. Monzillo L. U., Hamdy O., Horton E. S., Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance Obesity Research 2003 11 9 1048 1054 (Pubitemid 41151581)
98. Villareal D. T., Miller B. V. III, Banks M., Fontana L., Sinacore D. R., Klein S., Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults American Journal of Clinical Nutrition 2006 84 6 1317 1323 (Pubitemid 44912812)
99. Obisesan T. O., Leeuwenburgh C., Phillips T., C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 10 1874 1879 (Pubitemid 39350306)
100. Esposito K., Giugliano F., Di Palo C., Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial Journal of the American Medical Association 2004 291 24 2978 2984
101. Marfella R., Esposito K., Siniscalchi M., Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women Diabetes Care 2004 27 1 47 52
102. Esposito K., Pontillo A., Di Palo C., Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial Journal of the American Medical Association 2003 289 14 1799 1804
103. Esposito K., Pontillo A., Giugliano F., Association of low interleukin-10 levels with the metabolic syndrome in obese women Journal of Clinical Endocrinology and Metabolism 2003 88 3 1055 1058
104. Ito H., Ohshima A., Inoue M., Weight reduction decreases soluble cellular adhesion molecules in obese women Clinical and Experimental Pharmacology and Physiology 2002 29 5-6 399 404
105. Zahorska-Markiewicz B., Olszanecka-Glinianowicz M., Janowska J., Kocelak P., The effect of weight loss on serum concentrations of FAS and tumour necrosis factor alpha in obese women Endokrynologia Polska 2008 59 1 18 22
106. Bruun J. M., Stallknecht B., Helge J. W., Richelsen B., Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss European Journal of Endocrinology 2007 157 465 471
107. Olszanecka-Glinianowicz M., Zahorska-Markiewicz B., Kocelak P., Janowska J., Holecki M., Semik-Grabarczyk E., The effect of weight loss on serum concentration of interleukine-6 (IL-6) and insulin resistance Endokrynologia Polska 2006 57 2 131 135
108. Zahorska-Markiewicz B., Mizia-Stec K., Olszanecka-Glinianowicz M., Janowska J., Effect of weight reduction on serum ghrelin and TNF concentrations in obese women European Journal of Internal Medicine 2004 15 3 172 175
109. Olszanecka-Glinianowicz M., Zahorska-Markiewicz B., Kocelak P., Janowska J., Semik-Grabarczyk E., The effect of weight loss on inflammation in obese women with polycystic ovary syndrome Endokrynologia Polska 2008 59 1 13 17 (Pubitemid 351547472)
110. Salas-Salvad J., Bull M., Garca-Lorda P., Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss International Journal of Obesity 2006 30 12 1714 1720
111. Esposito K., Marfella R., Ciotola M., Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial Journal of the American Medical Association 2004 292 12 1440 1446
112. Ryan A. S., Nicklas B. J., Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women Diabetes Care 2004 27 7 1699 1705
113. Bruun J. M., Helge J. W., Richelsen B., Stallknecht B., Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects American Journal of Physiology 2006 290 5 E961 E967
114. Church T. S., Willis M. S., Priest E. L., Obesity, macrophage migration inhibitory factor, and weight loss International Journal of Obesity 2005 29 6 675 681
115. Nicklas B. J., Ambrosius W., Messier S. P., Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial American Journal of Clinical Nutrition 2004 79 4 544 551
116. You T., Berman D. M., Ryan A. S., Nicklas B. J., Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women Journal of Clinical Endocrinology and Metabolism 2004 89 4 1739 1746
117. Rokling-Andersen M. H., Reseland J. E., Veierod M. B., Effects of long-term exercise and diet intervention on plasma adipokine concentrations American Journal of Clinical Nutrition 2007 86 5 1293 1301
118. Giannopoulou I., Fernhall B., Carhart R., Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes Metabolism 2005 54 7 866 875
119. Aronne L. J., Therapeutic options for modifying cardiometabolic risk factors American Journal of Medicine 2007 120 3, supplement 1 S26 S34
120. Rucker D., Padwal R., Li S. K., Curioni C., Lau D. C. W., Long term pharmacotherapy for obesity and overweight: updated meta-analysis British Medical Journal 2007 335 7631 1194 1199
121. Hatzitolios A., Savopoulos C., Lazaraki G., Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia Indian Journal of Gastroenterology 2004 23 4 131 134
122. Torgerson J. S., Hauptman J., Boldrin M. N., Sjstrm L., XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients Diabetes Care 2004 27 1 155 161 (Pubitemid 38196725)
123. Bougoulia M., Triantos A., Koliakos G., Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women Hormones 2006 5 4 259 269
124. Yesilbursa D., Serdar A., Heper Y., The effect of orlistat-induced weight loss on interleukin-6 and C-reactive protein levels in obese subjects Acta Cardiologica 2005 60 3 265 269
125. Hsieh C.-J., Wang P.-W., Liu R.-T., Orlistat for obesity: benefits beyond weight loss Diabetes Research and Clinical Practice 2005 67 1 78 83
126. Brook R. D., Bard R. L., Glazewski L., Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults American Journal of Cardiology 2004 93 8 1012 1016
127. Borges R. L., Ribeiro-Filho F. F., Carvalho K. M. B., Zanella M. T., Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity Arquivos Brasileiros de Cardiologia 2007 89 6 409 414
128. Madsen E. L., Rissanen A., Bruun J. M., Weight loss larger than 10 is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study European Journal of Endocrinology 2008 158 2 179 187
129. Samuelsson L., Gottster A., Lindgrde F., Decreasing levels of tumour necrosis factor and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors Diabetes, Obesity and Metabolism 2003 5 3 195 201
130. Tziomalos K., Krassas G. E., Tzotzas T., The use of sibutramine in the management of obesity and related disorders: an update Vascular Health and Risk Management 2009 5 441 452
131. Bray G. A., Greenway F. L., Pharmacological treatment of the overweight patient Pharmacological Reviews 2007 59 2 151 184
132. Shechter M., Beigel R., Freimark D., Matetzky S., Feinberg M. S., Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease American Journal of Cardiology 2006 97 11 1650 1653
133. Valsamakis G., McTernan P. G., Chetty R., Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines Metabolism 2004 53 4 430 434
134. Jung S. H., Park H. S., Kim K.-S., Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss Journal of Nutritional Biochemistry 2008 19 6 371 375
135. Hung Y.-J., Chen Y.-C., Pei D., Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with type 2 diabetes Diabetic Medicine 2005 22 8 1024 1030
136. Nathan D. M., Buse J. B., Davidson M. B., Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapya consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Clinical Diabetes 2009 27 1 4 16
137. Hundal R. S., Inzucchi S. E., Metformin: new understandings, new uses Drugs 2003 63 18 1879 1894
138. Abbasi F., Chu J. W., McLaughlin T., Lamendola C., Leary E. T., Reaven G. M., Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus Metabolism 2004 53 2 159 164
139. Lund S. S., Tarnow L., Stehouwer C. D. A., Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes European Journal of Endocrinology 2008 158 5 631 641
140. De Jager J., Kooy A., Lehert P., Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial Journal of Internal Medicine 2005 257 1 100 109
141. Chu N. V., Kong A. P. S., Kim D. D., Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes Diabetes Care 2002 25 3 542 549
142. Eriksson A., Attvall S., Bonnier M., Eriksson J. W., Rosander B., Karlsson F. A., Short-term effects of metformin in type 2 diabetes Diabetes, Obesity and Metabolism 2007 9 3 330 336 (Pubitemid 46502051)
143. Katsiki N., Georgiadou E., Hatzitolios A. I., The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome Drugs 2009 69 11 1417 1431
144. Tsilchorozidou T., Mohamed-Ali V., Conway G. S., Determinants of interleukin-6 and C-reactive protein vary in polycystic ovary syndrome, as do effects of short- and long-term metformin therapy Hormone Research 2009 71 3 148 154
145. Jakubowska J., Bohdanowicz-Pawlak A., Milewicz A., Szymczak J., Bednarek-Tupikowska G., Demissie M., Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment Gynecological Endocrinology 2008 24 7 378 384
146. Diamanti-Kandarakis E., Paterakis T., Alexandraki K., Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin Human Reproduction 2006 21 6 1426 1431
147. Sari R., Eray E., Ozdem S., Akbas H., Coban E., Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women. Clinical and Experimental Medicine. In press
148. Bult M. J. F., van Dalen T., Muller A. F., Surgical treatment of obesity European Journal of Endocrinology 2008 158 2 135 145
149. Buchwald H., Avidor Y., Braunwald E., Bariatric surgery: a systematic review and meta-analysis Journal of the American Medical Association 2004 292 14 1724 1737
150. Adams T. D., Gress R. E., Smith S. C., Long-term mortality after gastric bypass surgery The New England Journal of Medicine 2007 357 8 753 761
151. Flum D. R., Dellinger E. P., Impact of gastric bypass operation on survival: a population-based analysis Journal of the American College of Surgeons 2004 199 4 543 551
152. Christou N. V., Sampalis J. S., Liberman M., Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients Annals of Surgery 2004 240 3 416 424
153. Sjstrm L., Narbro K., Sjstrm C. D., Effects of bariatric surgery on mortality in Swedish obese subjects The New England Journal of Medicine 2007 357 8 741 752
154. Nguyen N. T., Slone J. A., Nguyen X.-M. T., Hartman J. S., Hoyt D. B., A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs Annals of Surgery 2009 250 4 631 639
155. Angrisani L., Lorenzo M., Borrelli V., Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial Surgery for Obesity and Related Diseases 2007 3 2 127 132
156. Maggard M. A., Shugarman L. R., Suttorp M., Meta-analysis: surgical treatment of obesity Annals of Internal Medicine 2005 142 7 547 559
157. Sjstrm L., Lindroos A.-K., Peltonen M., Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery The New England Journal of Medicine 2004 351 26 2683 2693
158. Chen S.-B., Lee Y.-C., Ser K.-H., Serum C-reactive protein and white blood cell count in morbidly obese surgical patients Obesity Surgery 2009 19 4 461 466
159. Habib P., Scrocco J. D., Terek M., Vanek V., Mikolich J. R., Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis American Journal of Cardiology 2009 104 9 1251 1255
160. Emery C. F., Fondow M. D. M., Schneider C. M., Gastric bypass surgery is associated with reduced inflammation and less depression: a preliminary investigation Obesity Surgery 2007 17 6 759 763
161. Zagorski S. M., Papa N. N., Chung M. H., The effect of weight loss after gastric bypass on C-reactive protein levels Surgery for Obesity and Related Diseases 2005 1 2 81 85
162. Gletsu N., Lin E., Khaitan L., Changes in C-reactive protein predict insulin sensitivity in severely obese individuals after weight loss surgery Journal of Gastrointestinal Surgery 2005 9 8 1119 1128
163. Holdstock C., Lind L., Engstrom B. E., CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects International Journal of Obesity 2005 29 10 1275 1280
164. Agrawal V., Krause K. R., Chengelis D. L., Zalesin K. C., Rocher L. L., McCullough P. A., Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein Surgery for Obesity and Related Diseases 2009 5 1 20 26
165. Lin E., Phillips L. S., Ziegler T. R., Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss Diabetes 2007 56 3 735 742
166. Vazquez L. A., Pazos F., Berrazueta J. R., Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery Journal of Clinical Endocrinology and Metabolism 2005 90 1 316 322
167. Vilarrasa N., Vendrell J., Sanchez-Santos R., Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor- receptors, C-reactive protein and adiponectin in morbidly obese patients Clinical Endocrinology 2007 67 5 679 686
168. Shargorodsky M., Fleed A., Boaz M., Gavish D., Zimlichman R., The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity International Journal of Obesity 2006 30 11 1632 1638
169. Laimer M., Kaser S., Kranebitter M., Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women International Journal of Obesity 2005 29 5 498 501
170. van Dielen F. M. H., Buurman W. A., Hadfoune M., Nijhuis J., Greve J. W., Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery Journal of Clinical Endocrinology and Metabolism 2004 89 8 4062 4068
171. Kopp C. W., Kopp H.-P., Steiner S., Weight loss reduces tissue factor in morbidly obese patients Obesity Research 2003 11 8 950 956
172. Kopp H. P., Kopp C. W., Festa A., Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 6 1042 1047
173. Hanusch-Enserer U., Cauza E., Spak M., Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding International Journal of Obesity 2003 27 3 355 361
174. Laimer M., Ebenbichler C. F., Kaser S., Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention International Journal of Obesity 2002 26 5 659 662
175. Carroll J. F., Franks S. F., Smith A. B., Phelps D. R., Visceral adipose tissue loss and insulin resistance 6 months after laparoscopic gastric banding surgery: a preliminary study Obesity Surgery 2009 19 1 47 55
176. Hanusch-Enserer U., Zorn G., Wojta J., Non-conventional markers of atherosclerosis before and after gastric banding surgery European Heart Journal 2009 30 12 1516 1524
177. Manco M., Fernandez-Real J. M., Equitani F., Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women Journal of Clinical Endocrinology and Metabolism 2007 92 2 483 490
178. Hakeam H. A., ORegan P. J., Salem A. M., Bamehriz F. Y., Jomaa L. F., Inhibition of C-reactive protein in morbidly obese patients after laparoscopic sleeve gastrectomy Obesity surgery 2009 19 4 456 460
179. Lin L.-Y., Lee W.-J., Shen H.-N., Nitric oxide production is paradoxically decreased after weight reduction surgery in morbid obesity patients Atherosclerosis 2007 190 2 436 442
180. Schernthaner G.-H., Kopp H.-P., Kriwanek S., Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity Obesity Surgery 2006 16 6 709 715
181. Nijhuis J., van Dielen F. M. H., Fouraschen S. M. G., Endothelial activation markers and their key regulators after restrictive bariatric surgery Obesity 2007 15 6 1395 1399
182. Pontiroli A. E., Pizzocri P., Paroni R., Folli F., Sympathetic overactivity, endothelial dysfunction, inflammation, and metabolic abnormalities cluster in grade III (World Health Organization) obesity: reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding Diabetes Care 2006 29 12 2735 2738
183. Ybarra J., Blanco-Vaca F., Fernandez S., The effects of liposuction removal of subcutaneous abdominal fat on lipid metabolism are independent of insulin sensitivity in normal-overweight individuals Obesity Surgery 2008 18 4 408 414
184. Klein S., Fontana L., Young L., Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease The New England Journal of Medicine 2004 350 25 2549 2557
185. Giugliano G., Nicoletti G., Grella E., Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women British Journal of Plastic Surgery 2004 57 3 190 194
186. Selvin E., Paynter N. P., Erlinger T. P., The effect of weight loss on C-reactive protein: a systematic review Archives of Internal Medicine 2007 167 1 31 39
187. Ridker P. M., Danielson E., Fonseca F. A., Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial The Lancet 2009 373 9670 1175 1182
188. Morrow D. A., de Lemos J. A., Sabatine M. S., Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial Circulation 2006 114 4 281 288
189. Ridker P. M., Cannon C. P., Morrow D., C-reactive protein levels and outcomes after statin therapy The New England Journal of Medicine 2005 352 1 20 28